KIRSTEN DONNER: Open Payments
NPI 1518349505 · WAUSAU, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 18 payments from 12 companies in 2025. Trend: 2023 $422 · 2024 $289 · 2025 $436
Food & beverage: $356Education: $80
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $95 |
| Sage Therapeutics, LLC | 4 | $87 |
| ABBVIE INC. | 3 | $68 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Organon LLC | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Smith+Nephew, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Solventum Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: ZURZUVAE, LILETTA, INJECTAFER, NEXPLANON, MONOFERRIC, Pico 14, JOURNAVX, PREVENA.
Industry payments across WI — which companies pay providers there.
